Anticentromere antibodies (ACA) and anti-topoisomerase I (anti-top0 I) were assayed in serum samples from 355 patients: 89 with proximal scleroderma; 54 with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility , sclerodactyly , telangiectasias), without proximal scleroderma; 154
Prognostic significance of anticentromere antibodies and anti–topoisomerase i antibodies in Raynaud's disease. A prospective study
✍ Scribed by Ethan S. Weiner; Sabine Hildebrandt; Jean-Luc Senécal; Lesley Daniels; Steven Noell; France Joyall; André Roussin; William Earnshaw; Naomi F. Rothfield
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 912 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Antibodies against mannan, a component of the yeast Saccharomyces cerevisiae cell wall, are more frequently found in Crohn's disease (CD) patients with low levels of mannan-binding lectin (MBL). MBL concentration depends on genetic polymorphisms. The aim of this study was to evaluate whe
To date, only anti-glycophorin-A monoclonal antibodies (MAbs) have been widely used as anti-erythroid probes in the diagnosis of leukemias. We have examined blood, bonemarrow and lymph-node samples from 474 patients, adults and children, with different hemopoietic malignancies, using a panel of MAbs